But few Candida auris cases so far in U.S.
Date: Oct 5, 2017
Source: MedPage Today
Author: Michael Smith, North American Correspondent, MedPage Today
Excerpt:
A pathogenic fungus that only recently attracted the attention of researchers has multidrug-resistant (MDR) strains that can cause untreatable bloodstream infections, a CDC investigator said here.
“I never thought I’d be talking about a fungal superbug,” said Tom Chiller, MD, chief of the agency’s mycotic diseases branch.
Even when the fungus, Candida auris, is not completely resistant to the available antifungal drugs, it can be a challenge, Chiller told a symposium here at the annual IDWeek meeting, sponsored jointly by the Infectious Diseases Society of American (IDSA), the Pediatric Infectious Diseases Society (PIDS), the Society for Healthcare Epidemiology of America (SHEA), and the HIV Medicine Association (HIVMA).
The fungus, first reported in 2009 and since seen around the world, is readily transmitted since it colonizes both the skin and the environment, but is not easily identified or treated. And like other Candida species, it can cause severe invasive disease and death.
Link: https://www.medpagetoday.com/meetingcoverage/idweek/68343
